Editor's Note The Food & Drug Administration (FDA) on August 27 (updated September 2) issued a warning about alcohol-based hand sanitizers packaged in containers that may appear as food or drinks and could put consumers at risk of serious injury or death if ingested.( https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-warns-consumers-about-hand-sanitizer-packaged-food-and-drink-containers ) Some hand sanitizers are…

Read More

Editor's Note The US Department of Health and Human Services (HHS) and Department of Defense (DOD) on September 16 released two documents outlining a detailed strategy for delivering safe and effective COVID-19 vaccine doses to the American people as quickly and reliably as possible. The documents, which were developed in…

Read More

Editor's Note Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health told the Kaiser Health News on September 1 that a COVID-19 vaccine could be available earlier than expected if clinical trial results are overwhelmingly positive. An independent Data and…

Read More

Editor's Note In an interview with the Financial Times, Food & Drug Administration (FDA) Commissioner Stephen Hahn, MD, on August 30, said the FDA could fast-track approval of a COVID-19 vaccine before late-stage clinical trials are complete if regulators believe the benefits of doing so outweigh the risks. Dr Hahn…

Read More

Editor's Note In an August 21 letter, the Food & Drug Administration (FDA) warns that the use of passive protective barrier enclosures without negative pressure when treating patients (such as during intubation, extubation) who are known or suspected to have COVID-19 may pose increased health risk to patients and healthcare…

Read More

Editor's Note A Gallup poll of US adults conducted from July 20 to August 2 finds that 35% of those surveyed would not be interested in receiving a COVID-19 vaccine when one is approved by the Food & Drug Administration. The survey also finds that 41% of non-white Americans would…

Read More

Editor's Note The Food and Drug Administration (FDA) on July 24 reissued its emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR Test to include two new indications for use: Testing for individuals who do not have COVID-19 symptoms or who have no reason to suspect COVID-19 infection. Allowing for pooled…

Read More

Editor's Note The Department of Health and Human Services (HHS) and Department of Defense on July 22 announced an agreement with Pfizer to produce and deliver 100 million doses of its COVID-19 vaccine in the US, following manufacture and approval. Pfizer will deliver the doses, once the vaccine receives emergency…

Read More

Editor's Note Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine. Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach. Pfizer CEO Albert…

Read More

Editor's Note The National Institute of Allergy and Infectious Diseases director Anthony Fauci says COVID-19 vaccine candidates will start moving into late-stage clinical trials by the end of July, continuing through the summer and into fall, the July 2 Reuters reports. The director of the National Institutes of Health, Dr…

Read More